Cargando…

Systemic Lupus Induced by Messenger RNA Vaccination

Detalles Bibliográficos
Autores principales:	Voisin, Olivier, Raphaël, Etienne, Priollet, Pascal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mayo Foundation for Medical Education and Research 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247624/ https://www.ncbi.nlm.nih.gov/pubmed/35787868 http://dx.doi.org/10.1016/j.mayocp.2022.05.001

Ejemplares similares

Acute interstitial nephritis after messenger RNA-based vaccination
por: Czerlau, Cecilia, et al.
Publicado: (2021)

Stress induced by messenger ribonucleic acid (RNA) vaccination may reveal acute adrenal insufficiency
por: Mariette, C., et al.
Publicado: (2021)

Tuberculosis following two-dose SARS-CoV-2 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac)
por: Li, Xue, et al.
Publicado: (2023)

Systemic Lupus Erythematosus Following COVID-19 Vaccination
por: Salleh, Anna Farazilah Mohd, et al.
Publicado: (2022)

Relapse of class V lupus nephritis after vaccination with COVID-19 mRNA vaccine
por: Tuschen, Katharina, et al.
Publicado: (2021)

New-onset systemic lupus erythematosus beginning as class V lupus nephritis after COVID-19 vaccination
por: Zavala-Miranda, María Fernanda, et al.
Publicado: (2021)

Two complications in patients with systemic lupus erythematosus: lupus cystitis and lupus enteritis
por: Wang, Gang, et al.
Publicado: (2022)

An 88-year-old woman with acute disseminated encephalomyelitis following messenger ribonucleic acid-based COVID-19 vaccination
por: Shimizu, Mai, et al.
Publicado: (2021)

Disproportionality analysis of anaphylactic reactions after vaccination with messenger RNA coronavirus disease 2019 vaccines in the United States
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2021)

Cohort experience of second messenger RNA vaccine dose tolerance after an initial-dose reaction
por: Eastman, Jacqueline, et al.
Publicado: (2022)

Non-lupus Glomerulonephritis in a Patient with Systemic Lupus Erythematosus
por: Al-Mendalawi, Mahmood D.
Publicado: (2016)

Short-time interruption of second-line mycophenolate treatment in a patient with renal sarcoidosis enabled a marked antibody response to SARS-CoV-2 messenger RNA vaccine
por: Schnuelle, Peter, et al.
Publicado: (2021)

Evaluation of anaphylaxis risk by skin testing with coronavirus disease 2019 messenger RNA vaccines on patients with anaphylaxis
por: Pienkowski, Marek M., et al.
Publicado: (2022)

Delayed angioedema after administration of the severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine
por: Watts, Melissa M., et al.
Publicado: (2022)

HIV and Messenger RNA (mRNA) Vaccine
por: Khalid, Khizer, et al.
Publicado: (2021)

New-onset of juvenile systemic lupus erythematosus following COVID-19 vaccination: First case report
por: de Carvalho, Jozélio Freire
Publicado: (2023)

Orbital myositis in systemic lupus erythematosus
por: Hernandez Fustes, Otto J.
Publicado: (2021)

Assessment of 4 Doses of SARS-CoV-2 Messenger RNA–Based Vaccine in Recipients of a Solid Organ Transplant
por: Kamar, Nassim, et al.
Publicado: (2021)

Amlodipine-Induced Subacute Cutaneous Lupus
por: Ortega-Loayza, Alex G, et al.
Publicado: (2013)

Verrucous Disseminated Discoid Lupus Erythematosus with Plantar and Oral Lesions in the Absence of Systemic Lupus Erthyematosus
por: Manikkath, Sruthy, et al.
Publicado: (2018)

Lessons from SARS and MERS remind us of the possible therapeutic effects of implementing a siRNA strategy to target COVID‐19: Shoot the messenger!
por: Habtemariam, Solomon, et al.
Publicado: (2020)

Outcomes of allergic-type reactions after messenger RNA coronavirus disease 2019 vaccination at 3 military medical centers
por: St. Clair, Benjamin D., et al.
Publicado: (2022)

Antibody response to graded dosing of coronavirus disease 2019 messenger RNA vaccines after allergic reaction to first dose
por: Van Meerbeke, Sara W., et al.
Publicado: (2022)

Central nervous system lupus presenting as paranoia
por: Grover, Ridhima, et al.
Publicado: (2012)

Panniculitis as the first sign of systemic lupus erythematosus
por: Sanavi, Suzan, et al.
Publicado: (2011)

Encapsulation state of messenger RNA inside lipid nanoparticles
por: Brader, Mark L., et al.
Publicado: (2021)

Coronavirus disease 2019 (COVID-19) vaccination in systemic lupus erythematosus and anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Sim, Jackie, et al.
Publicado: (2021)

Risk of herpes zoster reactivation after messenger RNA COVID-19 vaccination: A cohort study
por: Birabaharan, Morgan, et al.
Publicado: (2022)

Integrative analysis of long non-coding RNAs and messenger RNA expression profiles in systemic lupus erythematosus
por: Luo, Qing, et al.
Publicado: (2018)

Bullous systemic lupus erythematosus associated with increased activity of lupus nephritis: a case report and review of the literature
por: Żychowska, Magdalena, et al.
Publicado: (2018)

Raynaud’s phenomenon in childhood-onset systemic lupus erythematous
por: Jiang, Qi, et al.
Publicado: (2022)

The necessity of stroke prevention in patients with systemic lupus erythematosus
por: Saadatnia, Mohammad, et al.
Publicado: (2012)

Aortoarteritis with systemic lupus erythematosus and secondary antiphopholipid syndrome
por: Chakrabarti, Nandini, et al.
Publicado: (2012)

A Case of Psoriasis Accompanied by Systemic Lupus Erythematosus
por: Kim, Eun Jee, et al.
Publicado: (2015)

Enterococcal Empyema and Trapped Lung in Systemic Lupus Erythematosus
por: Maharaj, Satish, et al.
Publicado: (2017)

Pityriasis lichenoides chronica induced by COVID-19 messenger RNA vaccination
por: Al Muqrin, Abdullah M., et al.
Publicado: (2022)

Spectrum of renal lesions in systemic lupus erythematosus: Six years’ experience at a tertiary health care centre in north east India
por: Raphael, V., et al.
Publicado: (2012)

Evaluation of Messenger RNA From COVID-19 BTN162b2 and mRNA-1273 Vaccines in Human Milk
por: Golan, Yarden, et al.
Publicado: (2021)

Serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with SARS-CoV-2 spike protein messenger RNA (mRNA) vaccines
por: Kozak, Kathryn E., et al.
Publicado: (2021)

Messenger RNA delivery to mitoribosomes – hints from a bacterial toxin
por: Bruni, Francesco, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_agum89sdu3a0ji84obaidh59os